Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Treasury Shares (2021 - 2025)

Lucid Diagnostics' Treasury Shares history spans 5 years, with the latest figure at $6.6 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 68.94% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $6.6 million, up 68.94%, while the annual FY2025 figure was $6.6 million, 68.94% up from the prior year.
  • Treasury Shares reached $6.6 million in Q4 2025 per LUCD's latest filing, roughly flat from $6.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $6.6 million in Q1 2025 to a low of $1.8 million in Q3 2023.
  • Average Treasury Shares over 5 years is $3.5 million, with a median of $2.3 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: decreased 17.19% in 2023, then skyrocketed 186.59% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $1.9 million in 2021, then increased by 7.76% to $2.1 million in 2022, then increased by 11.76% to $2.3 million in 2023, then skyrocketed by 66.74% to $3.9 million in 2024, then surged by 68.94% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Treasury Shares are $6.6 million (Q4 2025), $6.6 million (Q3 2025), and $6.6 million (Q2 2025).